A new CDC report found that benzodiazepines were prescribed at 27 annual physician visits per 100 adults from 2014 to 2016.
Flu vaccine effectiveness data are not available yet, but the latest flu-related death and hospitalization estimates are in.
A preemptive pain management program involving OTC medications can help reduce the need for opioid prescriptions following certain surgeries.
Older adults with diabetes are experiencing declines in all-cause mortality rates, whereas younger adults continue to be affected more by the condition.
Lefamulin was approved by the FDA in August 2019 for the treatment of CABP.
Quality, speed, and price has been referred to as the "Unattainable Triangle".
FDA approval decision expected in the second quarter of 2020.
Proton pump inhibitors (PPIs) may be linked to concentration and memory problems in individuals with a history of breast cancer.
As we head into a new year, Drug Topics® is exploring some of the latest pharmacy trends and how they will shape the industry in the next decade.
Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.